Intestinal and hepatic Niemann-Pick C1L1 proteins: Future therapeutic targets for cholesterol gallstones disease?

European Journal of Pharmacology

Volumn 728, Issue 1, 2014, Pages 77-81

  Guillermo Castro Torres, Ibrahim ^a   De La O Arciniega, Minarda ^b   Adolfo Bravo Duarte, Gustavo ^c   Gallegos Estudillo, Janeth ^c   Ángel Domínguez Ortíz, Miguel ^c   Martínez Vázquez, Mariano ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Cholesterol gallstones; Gallbladder; NPC1L1 proteins; Therapeutic target

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CHOLESTEROL; NIEMANN PICK C1 PROTEIN; NIEMANN PICK C1L1 PROTEIN; NIEMANN PICK C2 PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; NPC1L1 PROTEIN, HUMAN;

BILE SECRETION; BIOACCUMULATION; CHOLESTEROL STONE; CHOLESTEROL TRANSPORT; HUMAN; LIPID ABSORPTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; DRUG EFFECTS; GALLSTONES; GENE EXPRESSION; GENETICS; INTESTINE; LIVER; METABOLISM; MOLECULARLY TARGETED THERAPY; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CHOLESTEROL; GALLSTONES; GENE EXPRESSION; HUMANS; INTESTINES; LIVER; MEMBRANE PROTEINS; MOLECULAR TARGETED THERAPY;

EID: 84896733436     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.01.067     Document Type: Review

References (40)

1. V. Abeysuriya, K.I. Deen, and N.M. Navarathne Biliary microlithiasis, sludge, crystals, microcrystallization, and usefulness of assessment of nucleation time Hepatobiliary Pancreat. Dis. Int. 9 2010 248 253
2. E. Balboa, G. Morales, P. Aylwin, G. Carrasco, L. Amigo, J. Castro, A. Rigotti, and S. Zanlungo Niemann-Pick C2 protein expression regulates lithogenic diet-induced gallstone formation and dietary cholesterol metabolism in mice Lipids 47 2012 13 25
3. I.G. Castro-Torres Formación de cálculos biliares de colesterol: nuevos avances científicos GEN 66 2012 57 62
4. I.G. Castro-Torres, and G.A. Bravo-Duarte Proteínas de Niemann-Pick como objetivos terapéticos moleculares para el tratamiento de cálculos biliares de colesterol Rev. Biomed. 24 2013 65 71
5. I.G. Castro-Torres, and M. Martínez-Vázquez Transportadores de lípidos biliares: una revisión actualizada GEN 67 2013 49 57
6. S.C. Chuang, E. Hsi, and K.T. Lee Genetics of gallstone disease Adv. Clin. Chem. 60 2013 143 185
7. N.L. Cianciola, C.R. Carlin, and T.J. Kelley Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis Arch. Biochem. Biophys. 515 2011 54 63
8. W. Cui, Z.Y. Jiang, Q. Cai, R.Y. Zhang, W.Z. Wu, J.C. Wang, J. Fei, S.D. Zhang, and T.Q. Han Decreased NPC1L1 expression in the liver from Chinese female gallstone patients Lipids Health Dis. 9 2010 17
9. H.R. Davis Jr., A.M. Tershakovec, J.E. Tomassini, and T. Musliner Intestinal sterol transporters and cholesterol absorption inhibition Curr. Opin. Lipidol. 22 2011 467 478
10. H.R. Davis Jr, and S.W. Altmann Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter Biochim. Biophys. Acta 1791 2009 679 683
11. O. de Bario, B.A. Neuschwander-Tetri, M. Liu, P. Portincasa, and D.Q. Wang Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic fatty liver disease J. Lipids 2011 (PMID 22132342).
12. Deffieu, M.S., Pfeffer, S.R., 2011. Niemann-Pick type C1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc. Natl. Acad. Sci. 108, 18932-18936.
13. A. Di Ciaula, D.Q. Wang, L. Bonfrate, and P. Portincasa Current views on genetics and epigenetics of cholesterol gallstone disease Cholesterol 2013 (PMID 23691293).
14. E. Grenier, C. Garofalo, E. Delvin, and E. Levy Modulatory role of PYY in transport and metabolism of cholesterol in intestinal epithelial cells PLoS One 7 2012 e40992
15. M.P. Guarino, S. Cocca, A. Altomare, S. Emerenziani, and M. Cicala Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed World J. Gastroenterol. 19 2013 5029 5034
16. Z.Y. Jiang, C.Y. Jiang, L. Wang, J.C. Wang, S.D. Zhang, C. Einarsson, M. Eriksson, T.Q. Han, P. Parini, and G. Eggertsen Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients Biochem. Biophys. Res. Commun. 379 2009 49 54
17. J.K. Kim, S.M. Cho, S.H. Kang, E. Kim, H. Yi, E.S. Yun, D.G. Lee, H.J. Cho, Y.H. Paik, Y.K. Choi, S.J. Haam, H.C. Shin, and D.K. Lee N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice J. Gastroenterol. Hepatol. 27 2012 1745 1751
18. M. Krawczyk, D. Lütjohann, R. Schirin-Sokhan, L. Villarroel, F. Nervi, F. Pimentel, F. Lammert, and J.F. Miquel Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease Hepatology 55 2012 1507 1517
19. K.J. Maurer, M.C. Carey, and J.G. Fox Roles of infection, inflammation, and the immune system in cholesterol gallstone formation Gastroenterology 136 2009 425 440
20. N. Méndez-Sánchez, D. Zamora-Valdés, J.A. Flores-Rangel, J.A. Pérez-Sosa, F. Vásquez-Fernández, J.I. Lezama-Mora, G. Vázquez-Elizondo, G. Ponciano-Rodríguez, M.H. Ramos, and M. Uribe Gallstones are associated with carotid atherosclerosis Liver Int. 28 2008 402 406 (Pubitemid 351279589)
21. M.G. Morales, L. Amigo, E. Balboa, M. Acuña, J. Castro, H. Molina, J.F. Miquel, F. Nervi, A. Rigotti, and S. Zanlungo Deficiency of Niemann-Pick C1 protein expression protects against diet-induced gallstone formation in mice Liver Int. 30 2010 887 897
22. N. Nihei, V.R. Kotecha, J.D. Andrade, J.G. Fox, and M.C. Carey Administration of ursodeoxycholate failed to prevent sludge and/or gallstone formation in cholecystokinin-1(A) receptor-deficient mice Biomed. Res. 32 2011 401 416
23. P. Portincasa, A.D. Ciaula, L. Bonfrate, and D.Q. Wang Therapy of gallstone disease: What it was, what it is, what it will be World J. Gastrointest. Pharmacol. Ther. 3 2012 7 20
24. P. Portincasa, A. Moschetta, and G. Palasciano Cholesterol gallstone disease Lancet 368 2006 230 239 (Pubitemid 44037798)
25. P. Portincasa, and D.Q. Wang Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation? Hepatology 55 2012 1313 1316
26. C. Pramfalk, Z.Y. Jiang, and P. Parini Hepatic Niemann-Pick C1-like 1 Curr. Opin. Lipidol. 22 2011 225 230
27. A. Stein, D. Hermoni, A. Elis, and F.M. Konikoff Effect of ezetimibe on the prevalence of cholelithiasis World J. Gastroenterol. 18 2012 5789 5792
28. L.M. Stinton, and E.A. Shaffer Epidemiology of gallbladder disease: cholelithiasis and cancer Gut Liver 6 2012 172 187
29. W. Tang, L. Jia, Y. Ma, P. Xie, J. Haywood, P.A. Dawson, J. Li, and L. Yu Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver Biochim. Biophys. Acta 1811 2011 549 555
30. R.E. Temel, W. Tang, Y. Ma, L.L. Rudel, M.C. Willingham, Y.A. Ioannou, J.P. Davies, L.M. Nilsson, and L. Yu Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe J. Clin. Invest. 117 2007 1968 1978 (Pubitemid 47036331)
31. M.A. Valasek, J.J. Repa, G. Quan, J.M. Dietschy, and S.D. Turley Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters Am. J. Physiol. Gastrointest. Liver Physiol. 295 2008 G813 G822
32. D.Q. Wang, D.E. Cohen, and M.C. Carey Biliary lipids and cholesterol gallstone disease J. Lipid. Res. 50 2009 S406 S411
33. H.H. Wang, P. Portincasa, O. de Bari, K.J. Liu, G. Garruti, B.A. Neuschwander-Tetri, and D.Q. Wang Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol Eur. J. Clin. Invest. 43 2013 413 426
34. H.H. Wang, P. Portincasa, N. Mendez-Sanchez, M. Uribe, and D.Q. Wang Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones Gastroenterology 134 2008 2101 2110 (Pubitemid 351790745)
35. L.J. Wang, and B.L. Song Niemann-Pick C1-Like 1 and cholesterol uptake Biochim. Biophys. Acta 1821 2012 964 972
36. L.J. Wang, J. Wang, N. Li, L. Ge, B.L. Li, and B.L. Song Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers J. Biol. Chem. 286 2011 7397 7408
37. M. Xie, V.R. Kotecha, J.D. Andrade, J.G. Fox, and M.C. Carey Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis J. Physiol. 590 2012 1811 1824
38. Y. Yamanashi, T. Takada, J. Shoda, and H. Suzuki A novel function of NPC1L1 as a negative regulator of NPC2 protein Hepatology 55 2011 953 964
39. Y. Yamanashi, T. Takada, T. Yoshikado, J. Shoda, and H. Suzuki NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport Gastroenterology 140 2011 1664 1674
40. S. Zúñiga, H. Molina, L. Azocar, L. Amigo, F. Nervi, F. Pimentel, N. Jarufe, M. Arrese, F. Lammert, and J.F. Miquel Ezetimibe prevents cholesterol gallstone formation in mice Liver Int. 28 2008 935 947 (Pubitemid 352044442)